15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Ambev SA ADR, 0 rate it Buy or better, 4 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $2.88 to $3.50, so the covering firms are broadly aligned. The average target of $3.09 sits 1% below the current $3.12. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 4% this year and 5% next, consensus EPS building from about $0.05 next quarter toward $0.21 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Hold
Strong Buy00%
Buy00%
Hold480%
Sell120%
Strong Sell00%
Based on 5 analysts giving stock ratings to Ambev SA ADR.
As of Jul, 0 of 5 firms rate ABEV a Buy (4 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
ABEV EPS & revenue forecast
EPS · NEXT QUARTER
$0.05
Range $0.05 – $0.05 · 3 analysts · +12% YoY
Next period, 3 analysts expect Ambev SA ADR to earn $0.05 a share (range $0.05 – $0.05), versus $0.04 a year earlier. Full-year consensus is $0.20, growing to $0.21 the year after.
REVENUE · NEXT QUARTER
$22.2B
Range $21.9B – $22.4B · 3 analysts · +7% YoY
Revenue is expected to reach $22.2B (range $21.9B – $22.4B), +7.0% year-over-year. Full-year consensus is $91.9B, rising to $96.3B next year.
Top analysts covering Ambev SA ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ABEV.
#1
Benjamin Theurer
Barclays · Rank #72
Hold
$3.50+12.2% to target
Overall win rate
47%
+ Follow
#2
RA
Rodrigo Alcantara
UBS
Sell
$2.90-7.1% to target
Coverage
—
+ Follow
#3
NS
Nadine Sarwat
Bernstein
Hold
$2.88-7.7% to target
Coverage
—
+ Follow
#4
FU
Felipe Ucros
Scotiabank
Hold
No targeton ABEV
Coverage
—
+ Follow
#5
IS
Isabella Simonato
B of A Securities
Hold
$13.50+332.7% to target
Coverage
—
+ Follow
ABEV stock forecast FAQ
What is ABEV's average 12-month price target?+
The 3 analysts with a live target average $3.09 for Ambev SA ADR over the next 12 months, ranging from a $3.50 high to a $2.88 low.
Is ABEV stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 5 analyst ratings, 0 are Buy or Strong Buy, 4 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for ABEV?+
The Street-high target is $3.50 (Barclays), and the Street-low is $2.88 (Bernstein). The average of all 3 active targets is $3.09.
How many Wall Street analysts cover ABEV?+
5 analysts have an active rating on Ambev SA ADR, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering ABEV?+
Among analysts who currently cover ABEV, Benjamin Theurer of Barclays has the strongest overall Quantellect track record (Rank #72). Their current call is Hold with a $3.50 target.
What is Ambev SA ADR's projected EPS for next quarter?+
The consensus estimate is $0.05 per share (range $0.05 – $0.05) across 3 analysts. Full-year EPS is projected at $0.20, rising to $0.21 the following year.
How much revenue is Ambev SA ADR expected to report next quarter?+
Consensus revenue is $22.2B (range $21.9B – $22.4B). Full-year revenue is projected at $91.9B, growing to $96.3B next year.
Have analysts been upgrading or downgrading ABEV lately?+
As of Jul, 0 of 5 firms rate ABEV a Buy (4 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ABEV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
